Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|January 12, 2022
Specific TCR V-J gene segment recombinations leading to the identification pan-V-J CDR3s associated with survival distinctions: diffuse large B-cell lymphomaKonrad J Cios, Taha I Huda, Rachel A Eakins, et al.
Current Genomics|June 30, 2017
Identification of Sets of Cytoskeletal Related and Adhesion-related Coding Region Mutations in the TCGA Melanoma Dataset that Correlate with a Negative OutcomeJohn M Yavorski, Rebecca J Stoll, Mohammad D Samy, et al.
Cell Cycle (Georgetown, Tex.)|February 13, 2024
B-cell ALL with SOX11 gene amplification associates with a worse outcomeGeorge Angelakakis, Mallika Varkhedi, Toriana R Dabkowski, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|February 7, 2018
Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced SurvivalJacob C Kinskey, Yaping N Tu, Wei Lue Tong, et al.
Anticancer Research|April 3, 2020
B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival RateYaping N Tu, Wei Lue Tong, Blake M Callahan, et al.
Human Vaccines & Immunotherapeutics|January 14, 2017
Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancerWei Lue Tong, Yaping N Tu, Mohammad D Samy, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2016
T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancerMohammad D Samy, Wei Lue Tong, John M Yavorski, et al.
Molecular Immunology|November 10, 2019
TRAV gene segments further away from the TRAJ gene segment cluster appear more commonly in human tumor and blood samplesNagehan Pakasticali, Tommy Gill, Boris I Chobrutskiy, et al.
Drug Discovery Today|February 21, 2015
Anticipating designer drug-resistant cancer cellsMark L Frangione, John H Lockhart, Daniel T Morton, et al.
Molecular Immunology|May 2, 2021
High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancerBoris I Chobrutskiy, Andrea Chobrutskiy, Saif Zaman, et al.
Pageof 15